Clinical Trial Update: A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

View source ↗

Summary

A completed study evaluating the demographics and outcomes of prostate cancer patients in Italy treated with a 6-month formulation of triptorelin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Ipsen | Conditions: Prostate Cancer | Status: COMPLETED